Sanofi’s New CEO Brandicourt Will Face Diabetes And Launch Challenges

But analysts say Olivier Brandicourt’s breadth of experience and cardiology strengths bode well for Sanofi, which can now close an unpleasant and very public boardroom shakeup and get on with needed business.

Sanofi has appointed Olivier Brandicourt as Chief Executive Officer, joining the firm from Bayer HealthCare LLC where he was chairman of the board of management and a member of the executive council.

A French national, Brandicourt is an industry veteran with 28 years of experience and is a physician by training. Before moving to Bayer AG in 2013, Brandicourt was president and general manager of Pfizer Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from France

More from Europe